Print Page     Close Window     

SEC Filings

8-K
SERES THERAPEUTICS, INC. filed this Form 8-K on 03/06/2019
Entire Document
 


SERES THERAPEUTICS, INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

 

     December 31,  
     2018     2017  

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 85,820     $ 36,088  

Investments

     —         113,895  

Prepaid expenses and other current assets

     6,845       5,095  
  

 

 

   

 

 

 

Total current assets

     92,665       155,078  

Property and equipment, net

     26,294       32,931  

Restricted investments

     1,400       1,400  

Restricted cash

     113       113  
  

 

 

   

 

 

 

Total assets

   $ 120,472     $ 189,522  
  

 

 

   

 

 

 

Liabilities and Stockholder’s Equity (Deficit)

    

Current liabilities:

    

Accounts payable

   $ 6,415     $ 7,033  

Accrued expenses and other current liabilities

     15,207       12,513  

Deferred revenue - related party

     20,419       12,079  
  

 

 

   

 

 

 

Total current liabilities

     42,041       31,625  

Lease incentive obligation, net of current portion

     7,250       8,989  

Deferred rent

     2,216       2,233  

Deferred revenue, net of current portion - related party

     116,840       84,847  

Other long-term liabilities

     170       1,129  
  

 

 

   

 

 

 

Total liabilities

     168,517       128,823  
  

 

 

   

 

 

 

Commitments and contingencies

    

Stockholders’ equity (deficit):

    

Preferred stock, $0.001 par value; 10,000,000 shares authorized at December 31, 2018 and 2017; no shares issued and outstanding at December 31, 2018 and 2017

     —         —    

Common stock, $0.001 par value; 200,000,000 shares authorized at December 31, 2018 and 2017; 40,936,735 and 40,571,015 shares issued and outstanding at December 31, 2018 and 2017

     41       40  

Additional paid-in capital

     341,284       324,376  

Accumulated other comprehensive income (loss)

     —         (146

Accumulated deficit

     (389,370     (263,571
  

 

 

   

 

 

 

Total stockholders’ equity (deficit)

     (48,045     60,699  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity (deficit)

   $ 120,472     $ 189,522  
  

 

 

   

 

 

 

© Seres Therapeutics. All Rights Reserved.